An independent academic team commissioned to critically evaluate a manufacturer's submitted evidence, informing the appraisal committee's deliberations.
HTA & Reimbursement
Terms for how health technology assessment bodies appraise new technologies and reach funding decisions.
- Topic: HTA & Reimbursement
- 43 terms
- Editor reviewed
The concluding, binding decision issued by an assessment body following its full appraisal process, determining a technology's funding status.
The German Federal Joint Committee, the highest decision-making body within statutory health insurance determining which services are covered, informed by IQWiG.
The French National Authority for Health, conducting assessment including SMR and ASMR ratings that inform pricing and reimbursement decisions.
A broad term covering any intervention used to promote health, prevent or treat disease, or improve rehabilitation and long-term care.
A multidisciplinary assessment of a health technology’s clinical, economic, organisational, social and ethical implications undertaken to support policy and practice decisions.
A systematic process identifying, tracking, and prioritising emerging technologies likely to significantly affect a health system, before market entry.
The overall sequence of steps a body follows, from scoping and submission through technical review to a final recommendation.